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Background
Infection with the human T-cell leukemia virus-1 (HTLV-
1) results in a variety of diseases including adult T-cell
leukemia/lymphoma (ATL). The pathogenesis of these
disorders is poorly understood, however involves com-
plex interactions with the host immune system. Previous
studies from our laboratory and others have suggested
that immune activation of infected T-cells increases the
expression of the oncogenic HTLV-1 Tax transactivator
protein from integrated HTLV-1 proviruses [1]. Thus, we
have hypothesized that immune activation of infected T-
cells may play an important role in disease pathogenesis
through Tax induction, leading to increased proliferation
of infected cells. To study this hypothesis, we employed
transgenic mice in which Tax is regulated by the HTLV-1
LTR. These mice were previously shown to develop neu-
rofibromas, but do not express Tax in T cells and do not
develop lymphomas [2].
Results
A single round of T-cell receptor-stimulation of transgenic
mouse LTR-Tax CD4+T-cells induced Tax expression,
hyperproliferation, and immortalization in culture. The
transition to cellular immortalization was accompanied
by markedly increased expression of the anti-apoptotic
gene, mcl-1, previously implicated as important in T-cell
survival. Immortalized cells exhibited a CD4+CD25+CD3-
phenotype commonly observed in ATL. Engraftment of
immune-activated LTR-Tax CD4+T-cells into NOD/Shi-
scid/IL-2Rγ null mice resulted in a leukemia-like pheno-
type with expansion and tissue infiltration of Tax+,
CD4+lymphocytes. Furthermore, immune activated Tax
CD4+ T-cells express CD4+ cell subset characteristics of
several different CD4+ T-cell subtypes, including Th1,
Th2, and Th17 cells, suggesting that HTLV-1 Tax induces
changes in the normal pattern of CD4+ subtype specifica-
tion. On-going studies are also employing retroviral-
mediated, insertional mutagenesis to identify cellular
genes that may collaborate with Tax in the induction of T-
cell lymphomas in the HTLV-1 LTR-Tax transgenic mice.
Conclusion
Immune activation of infected CD4+T-cells results in the
induction of Tax expression in CD4+cells from LTR-Tax
transgenic mice as well as in infected human CD4+T-cells.
This may lead to T-cell proliferation, additional genetic
alterations, cellular immortalization and pathogenesis of
HTLV-1-asssociated diseases including ATL in infected
individuals.
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